DEERFIELD, Ill.--(BUSINESS WIRE)--TerSera Therapeutics LLC announced today the presentation of new real-world analyses on the treatment patterns of goserelin in women with breast cancer. The data were ...

DEERFIELD, Ill.-- (BUSINESS WIRE)--TerSera Therapeutics LLC announced today that The National Comprehensive Cancer Network® (NCCN) Breast Cancer Panel included both goserelin 3.6 mg every 4 weeks and ...

Goserelin is a type of hormone therapy. It is also known as Zoladex. You pronounce goserelin as gos-er-e-lin. This page is about goserelin for breast cancer in women who haven’t gone through menopause ...

WASHINGTON, May 30 (UPI) --The drug goserelin, sold by AstraZeneca under the brand name Zoladex, may help protect the ovaries of women with breast cancer. "It's not a panacea, but based on these data, ...

Goserelin, a lutenizing hormone-releasing hormone agonist, reduces the long-term risk of disease recurrence and deaths in premenopausal women with early breast cancer who did not take tamoxifen, ...

The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. ZOLADEX 3.6 mg contains the active ingredient goserelin acetate.

AstraZeneca is offloading yet another set of drug rights to streamline its portfolio and raise some cash. The U.K.-based drugmaker has agreed to hand over its cancer drug Zoladex in the U.S. and ...